DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

Description

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

Conditions

Open Angle Glaucoma (OAG)

Talk to us

Study Overview

On this page

Study Details

Study overview

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

Condition
Open Angle Glaucoma (OAG)
Intervention / Treatment

-

Contacts and Locations

Mesa

Barnet Dulaney Perkins Eye Centers, Mesa, Arizona, United States, 85206

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Primary open angle glaucoma
  • * Patients age 30 or greater with an IOP of 18-26 mmHg
  • * Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
  • * DSLT procedure
  • * History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
  • * Angle closure patients
  • * Ocular Hypertension
  • * Baseline VF MD of worse than -12dB
  • * Uncontrolled systemic microvascular disease (eg. HTN, DM)
  • * Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

Ages Eligible for Study

30 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Barnet Dulaney Perkins Eye Centers,

Christine Funke, Medical Doctor, PRINCIPAL_INVESTIGATOR, Barnet Dulaney Perkins Eye Centers

Study Record Dates

2027-12-31